Colon Cancer Screening Guidelines: Everything to Know About Your Options
Colorectal cancer is one of the most preventable cancers, yet it remains one of the top causes of cancer-related deaths in the United States. That gap between what is possible and what is actually happening comes down, in large part, to this: colon cancer screening guidelines and recommendations.
When colon cancer is found at a localized stage before it has spread, the five-year relative survival rate is about 91 percent. When it is caught after the cancer has spread to distant parts of the body, that number drops to approximately 13 percent. The difference is early detection.
Understanding the updated colon cancer screening guidelines and recommendations is not just a matter of following your doctor’s advice. It is one of the most concrete, evidence-backed steps you can take to protect your long-term health.
Whether you are approaching a screening milestone, sorting through your colorectal cancer screening options or trying to understand how your personal or family history changes the picture, our guide covers everything you need to know.
We will walk through what colorectal cancer (CRC) screening recommendations currently say, why those recommendations changed, what different CRC screening tests involve, how prior findings affect your future schedule and when symptoms should prompt action, regardless of your age.
New Guidelines: What is the updated recommended age for colon cancer screening?
For many years, the guidelines recommended a starting age for colorectal cancer screening of 50. That changed in May 2021, when the U.S. Preventive Services Task Force (USPSTF) updated its colon cancer screening guidelines to recommend that all average-risk adults begin colon cancer screening at age 45.
The American Cancer Society had moved to the same recommendation in 2018, and the USPSTF update brought federal policy in line with that position.
Under the current colon cancer screening guidelines, routine screening is recommended for adults through age 75.
For those between 76 and 85, the USPSTF guidelines recommend an individualized approach to colon cancer screening based on each person’s overall health, prior screening history and personal preferences. For adults over 85, routine screening is generally no longer advised.
In practical terms, this means that if you are 45 or older and have not yet started screening for colon cancer, the updated colorectal cancer screening guidelines say it is time to begin.
If you are between 45 and 49 and currently feel healthy, that is exactly the population these updated CRC screening recommendations are designed to reach.
Why did the colon cancer screening recommendations and guidelines change?
The shift in colon cancer screening age from 50 to 45 was driven by a documented and concerning trend: colorectal cancer rates have been rising steadily in adults under 55 for more than two decades.
According to American Cancer Society data, the proportion of colorectal cancer cases among adults younger than 55 grew from 11 percent of all cases in 1995 to 20 percent in 2019. That means one in five people diagnosed with colorectal cancer today is under 55.
For men, colorectal cancer is currently the top cause of death, and for women, it’s the second leading cause.
Researchers point to a combination of lifestyle and environmental factors as contributing to this trend, including high consumption of ultra-processed foods, sedentary behavior and changes in gut microbiome health. The exact mechanisms are still being studied, but the trend itself is not in question.
Modifying the guidelines and lowering the recommended age for colon cancer screening to 45 gives providers an opportunity to find precancerous polyps or early-stage cancers before they cause symptoms, when treatment is most effective and intervention is least invasive. The updated colorectal cancer screening guidelines reflect a broader commitment to prevention over reaction.
What are doctors looking for when they perform a colon cancer screening?
A colon cancer screening is not simply a test to confirm whether colorectal cancer is present. It is a comprehensive evaluation of the colon and rectum designed to identify a range of findings that exist along a spectrum from benign to potentially dangerous.
Understanding what providers are actually looking for can help reduce the anxiety that often surrounds colorectal cancer screening options and clarify why early action matters.
The primary targets of colorectal cancer screening include:
- Adenomatous polyps (adenomas): These are growths on the inner lining of the colon or rectum and are the most clinically important finding in colorectal cancer (CRC) screening. Most polyps are benign, but adenomas have the potential to develop into cancer over time, typically over a period of 10 to 15 years. Identifying and removing them before that transformation occurs is one of the most powerful benefits of regular screening for colon cancer, and this is a big reason the guidelines have changed.
- Flat or sessile serrated lesions: These polyps lie flat against the colon wall rather than protruding inward, which can make them harder to detect. Sessile serrated lesions are associated with a specific molecular pathway that can progress to colorectal cancer, often more quickly than traditional adenomas. Thorough colon examination, not just identification of obvious growths, is what drives the value of quality CRC screening options.
- Colorectal cancer: Screening can detect early-stage cancers before any symptoms appear. Many people who are ultimately diagnosed with colorectal cancer had no idea anything was wrong at the time it was found during a routine exam.
Blood or abnormal DNA in stool: Stool-based CRC screening tests are designed to detect molecular signals that may indicate the presence of cancer or precancerous tissue, even when no visible abnormality is present during a physical examination.
It is also worth knowing that not every finding during a colon cancer screening test leads to the same response. Some polyps are removed during the same examination in which they are discovered. Others may prompt a follow-up schedule for monitoring.
An abnormal result from a colon cancer screening test is not a cancer diagnosis, and many people who receive one go on to have entirely benign findings confirmed on further evaluation.
How do the colon cancer screening guidelines change when you have a family history of bowel cancer?
Family history is one of the most significant factors in determining when and how frequently you should be undergoing screening for colon cancer. Having a first-degree relative, meaning a parent, sibling or child, who has been diagnosed with colorectal cancer or advanced polyps raises your personal risk meaningfully and changes the colon cancer screening recommendations and guidelines that apply to you.
First-Degree Relative Diagnosed Before Age 60
If you have a first-degree relative who was diagnosed with colorectal cancer or advanced polyps before age 60, or if you have two or more first-degree relatives diagnosed at any age, the American College of Gastroenterology guidelines recommend beginning colon cancer screening at age 40 or 10 years before the youngest affected relative’s age of diagnosis, whichever comes first. You should also be screened more frequently than average-risk individuals.
First-Degree Relative Diagnosed at 60 or Older
If you have a single first-degree relative diagnosed at age 60 or older, you may still benefit from beginning screening earlier than the standard age of 45, often around age 40.
Guidance from the American Academy of Family Physicians notes that individuals in this category should discuss their personal screening timeline with their provider, as recommendations may align with the average-risk colon cancer screening schedule or call for an accelerated approach depending on other factors in their history.
Hereditary Colorectal Cancer Syndromes
When a family history is particularly strong, involves multiple generations or includes colorectal cancer at unusually young ages, a hereditary syndrome may be at play. Two of the most important to know about are:
- Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer): Lynch Syndrome is the most common hereditary colorectal cancer syndrome. People with known Lynch Syndrome gene mutations are typically advised to begin colorectal cancer screening in their early 20s or 2 to 5 years before the youngest family member’s diagnosis age, whichever comes first. Screening intervals are also significantly shorter, with the guidelines advising every one to two years rather than the longer intervals used for average-risk adults.
- Familial Adenomatous Polyposis (FAP): FAP causes hundreds of polyps to develop throughout the colon and rectum, and the lifetime risk of colorectal cancer in people with untreated FAP approaches nearly 100 percent. Screening for FAP typically begins around age 10 to 12 and involves annual examinations. Genetic counseling and testing are strongly recommended for families with a suspected or confirmed FAP diagnosis.
If you are unsure whether a hereditary syndrome may be present in your family, a conversation with your primary care provider is the right starting point. They can help evaluate your history and refer you to genetic counseling if appropriate.
Sharing your family history proactively, even when you feel completely healthy, is one of the most important things you can do as part of your colon cancer screening plan.
What symptoms may warrant colon cancer screening without family history or meeting age guidelines?
While routine colorectal cancer screening is typically guided by age and risk factors, there are symptoms that should prompt a conversation with your provider, regardless of whether you fall within a standard screening category.
These symptoms can have many causes and are not necessarily colorectal cancer. However, the presence of any of them deserves thorough testing, rather than a wait-and-see approach.
Symptoms that may warrant earlier or unscheduled colon cancer screening include:
- Rectal bleeding or blood in the stool: This is one of the most commonly reported early warning signs for colorectal cancer in younger adults. It is easy to attribute rectal bleeding to hemorrhoids or other benign causes, and sometimes that is accurate. But it is also the most frequently documented early symptom in adults under 50 who are later diagnosed with colorectal cancer. It deserves evaluation.
- Persistent changes in bowel habits: Changes in frequency, consistency or the shape of stool that last more than a few weeks should be discussed with a provider. A one-time shift is often unremarkable. A pattern that persists is worth investigating with further screening.
- Unexplained abdominal pain or cramping: Chronic or recurring abdominal discomfort, bloating or cramping that does not resolve and has no clear explanation is worth discussing with your care team.
- A sensation of incomplete emptying: Feeling that your bowel does not fully empty after a bowel movement can sometimes indicate a growth or structural change in the lower colon or rectum.
- Unexplained weight loss or fatigue: Significant, unintentional weight loss or persistent fatigue without an obvious cause can be associated with colorectal and other cancers and warrants clinical attention.
- Iron deficiency anemia without a clear cause: Slow, chronic bleeding in the colon can lead to iron deficiency anemia before visible blood appears in the stool. If you have been told you are anemic without an obvious explanation, your provider may recommend evaluation of your gastrointestinal tract.
The point of listing these symptoms is not to create unnecessary worry. Oftentimes, they have benign explanations. The point is to reinforce that the colon cancer testing recommendations and guidelines based on age and family history are designed for people who have no symptoms.
If you are experiencing any of the above, you do not need to wait for a scheduled screening milestone. Talk to your primary care provider.
What happens if your colon cancer screening comes back abnormal?
An abnormal colorectal cancer screening result is one of the most anxiety-inducing moments in the process, and it is also one of the most commonly misunderstood.
An abnormal colon cancer screening result does not necessarily mean you have cancer; it means something was detected that warrants a closer look.
For most people, that closer look confirms either a benign finding or the early removal of a precancerous polyp.
Here is what typically happens following different types of abnormal colon cancer screening results:
- Abnormal stool-based test result: If a FIT test, gFOBT or stool DNA test returns a positive result, the standard next step is a follow-up visual screening examination of the colon and rectum. Stool-based tests are designed to flag potential abnormalities, not to diagnose them. A positive stool test confirms that further evaluation is needed, not that cancer is present.
- Polyps found during a colonoscopy: Small polyps are commonly removed during the same procedure in which they are found, often without any interruption to the colon cancer screening exam. The removed tissue is sent to a pathology lab to determine the type and risk level of the polyp, which also informs your next surveillance interval.
- Larger or more complex findings: If a larger growth is identified during a colon cancer screening and cannot be fully removed during the initial procedure, next steps may include a return visit for removal, a biopsy or referral to a specialist. This is uncommon in routine colon screenings, but it does occur.
- Abnormal Shield blood test result: A positive result from the Shield test indicates that DNA changes associated with colorectal cancer or advanced polyps were detected in the bloodstream. A positive result should always be followed up with a colonoscopy. It is also important to understand that a negative Shield result does not guarantee the absence of precancerous lesions, given the test’s limited sensitivity for polyp detection.
Pathology results from removed polyps are typically available within one to two weeks of the procedure. Your provider will use those findings to determine your personalized follow-up schedule.
The most meaningful takeaway from an abnormal result is that you completed the necessary screening and are now in a position to act on what was found. That is exactly the purpose of routine colon cancer screening.
The Different Types of Colorectal Cancer (CRC) Screening Tests
The current colorectal cancer screening guidelines support a range of testing options, and the best choice depends on your risk level, personal preferences, access to care and your prior screening history.
Below is a breakdown of the colon cancer screening options available to average-risk adults today.
Visual and Structural Colon Cancer Screening Exams
Visual exams allow providers to directly examine the lining of the colon and rectum and to remove any polyps found during the same visit.
Colonoscopy: When it comes to colon cancer screening, this is considered the gold standard test. Not only can polyps be identified during the procedure itself, but they can also be removed. When it comes to stool and blood-based tests, positive results will warrant a follow-up colonoscopy, which is why many providers simply recommend the colonoscopy from the get-go.
Flexible Sigmoidoscopy: This colon cancer screening procedure examines the lower portion of the colon using a thin, flexible scope. It is performed every five years for average-risk individuals and is sometimes combined with annual FIT testing as a two-component approach. It generally does not require full bowel preparation and no sedation is typically needed.
CT Colonography (Virtual Exam): CT colonography is a colon cancer screening test that uses computed tomography imaging to produce detailed pictures of the entire colon and rectum without the use of an internal scope. It is performed every five years and does require bowel preparation. No sedation is involved. If significant findings are detected, a follow-up visual procedure will be needed to remove any polyps.
Stool-Based Colon Cancer Screening Tests
Stool-based colon cancer screening tests are non-invasive, can be completed at home and do not require any preparation that affects your normal routine.
A positive stool-based test should always be followed up with a visual CRC examination/screening.
Fecal Immunochemical Test (FIT): Can identify blood in the stool by using antibodies. This colon cancer screening test is performed annually, requires no dietary restrictions beforehand and involves collecting a small stool sample at home that is mailed to a lab. It is among the most widely used and accessible colon cancer testing options available and is recommended as a first-tier CRC screening test.
High-Sensitivity Guaiac Fecal Occult Blood Test (gFOBT): Like FIT, gFOBT looks for blood in the stool, but it uses a chemical rather than an antibody-based detection method. It is recommended that this colorectal cancer screening be performed annually and requires some dietary adjustments in the days before sample collection, such as avoiding certain foods and medications that can produce a false positive.
Stool DNA Test (Cologuard): Cologuard combines FIT technology with DNA biomarker analysis to detect both blood and abnormal cell DNA shed from the colon lining into the stool. This form of colon cancer screening is performed every one to three years, requires no preparation and is approved for average-risk adults aged 45 and older. A positive test result requires follow-up with a visual exam.
Blood-Based Colon Cancer Screening Tests
Shield (Cell-Free DNA Blood Test) is the first FDA-approved blood test for primary colorectal cancer screening, approved in July 2024 for average-risk adults aged 45 and older. It works by detecting circulating cell-free DNA changes in the bloodstream that may signal the presence of a colorectal tumor.
In the ECLIPSE study that supported its approval, the Shield test detected colorectal cancer in 83 percent of participants confirmed to have it. Its sensitivity for precancerous adenomatous polyps is considerably lower, approximately 13 percent, which is a meaningful limitation when choosing a CRC screening test.
A positive Shield result must always be followed by a visual colon cancer screening examination. Shield is not intended for use in high-risk individuals or as a replacement for surveillance in those with prior findings.
It is worth noting that the USPSTF’s 2021 guidance did not include blood-based tests in its formal CRC screening recommendations due to limited evidence at the time.
However, the National Comprehensive Cancer Network updated its guidelines in June 2025 to include Shield as the first FDA-approved blood test option for primary CRC screening.
Much like the update in guidelines, the landscape of acceptable colorectal cancer screening options continues to evolve. Your primary care provider can help you determine whether Shield is an appropriate choice given your risk profile and history.
Across all of these options, the single most important thing is completing whichever colon cancer screening test you choose on schedule. A test that is completed consistently, even if it is not the most sensitive option available, will always outperform a more accurate test that is continually deferred.
What is the recommended frequency for colon cancer screening?
Screening frequency is one of the most commonly misunderstood aspects of the new colon cancer screening guidelines. The interval between screenings is not the same for everyone and depends on which test you use, what your prior results showed and your overall risk level.
For average-risk adults with no prior abnormal findings, general intervals based on test type are as follows:
- FIT or gFOBT: Annually
- Stool DNA (Cologuard): Every 1 to 3 years
- Flexible sigmoidoscopy: Every 5 years (sometimes paired with annual FIT)
- CT colonography: Every 5 years
- Visual exam of the full colon and rectum: Every 10 years for average-risk adults with a completely normal result
For higher-risk individuals, including those with a strong family history, prior polyp findings or a hereditary syndrome, colon cancer screening intervals are shorter.
The preferred method for higher-risk screening is generally a visual examination rather than a stool-based or blood-based test, and your provider will establish a schedule based on your individual history and risk for colorectal cancer.
It is also important to understand that if a stool-based or blood-based test returns a positive result, that 10-year clock does not simply reset.
A positive result requires follow-up with a visual exam, and your future intervals will be determined by what that examination finds. This distinction is at the heart of why following through on follow-up care after an abnormal test result is just as important as completing the initial colon cancer screening.
What does colon cancer screening look like after a prior polyp diagnosis?
If you have already had a polyp identified and removed during a prior colon cancer screening test, you now have a personalized surveillance schedule. Staying current with that schedule is critical.
The follow-up intervals recommended after polyp removal are not arbitrary. They are based on the number, size and type of polyps found, all of which are associated with different levels of future risk.
The following general colon cancer screening intervals are based on the U.S. Multi-Society Task Force on Colorectal Cancer consensus guidelines for average-risk adults. If you have a hereditary syndrome, inflammatory bowel disease or a significant family history of colorectal cancer, your intervals may differ:
- 1 to 2 small tubular adenomas (under 10 mm, no high-grade features): Repeat visual examination in 7 to 10 years. Research has shown that people with this finding carry a future cancer risk similar to those who had a completely normal exam.
- 3 to 4 tubular adenomas under 10 mm: Repeat visual examination in 3 to 5 years.
- High-risk adenoma (10 mm or larger, tubulovillous or villous features, or high-grade dysplasia): Repeat visual examination in 3 years. These findings are associated with a meaningfully elevated risk of advanced neoplasia (abnormal growth of tissues/cells) at follow-up.
- More than 10 adenomas at a single examination: Repeat visual examination in 1 year. This finding may also prompt evaluation for a hereditary polyposis syndrome.
- 1 to 2 sessile serrated polyps under 10 mm: Repeat visual examination in 5 to 10 years.
- Sessile serrated polyps with dysplasia, or 3 or more sessile serrated polyps: Repeat visual examination in 3 years.
- Small hyperplastic polyps in the rectum or sigmoid colon (under 10 mm): No elevated risk beyond baseline. Return to the standard colon cancer screening schedule, typically 10 years after a normal exam.
One of the most common points of confusion after a polyp diagnosis is the distinction between screening and surveillance.
After a polyp is found and removed, you are no longer on a standard colorectal cancer screening schedule. You are on a surveillance schedule, and those two things are meaningfully different in terms of frequency and method.
If you are unsure what your prior findings placed you on, your primary care provider can review your pathology records, clarify your current schedule and answer any questions about what your next steps should be.
Not sure whether the colon cancer screening guidelines apply to you? We’re here to help.
Navigating the updated colon cancer screening guidelines can feel complicated, especially when your personal history, family background or prior test results put you in a category that does not fit the standard timeline.
At Aspen Valley Health, our primary care team is here to help you understand exactly where you stand with CRC screening recommendations.
Whether you are turning 45 and thinking about colon cancer screening for the first time, coming off a prior polyp diagnosis and trying to sort out your surveillance schedule or managing a family history that puts you in a higher-risk category, a primary care visit is the right starting point.
During that appointment, your provider will review your personal and family health history, help you understand which colorectal cancer screening options make sense given your circumstances and work with you to create a plan that’s right for you.
Colorectal cancer is highly preventable when the right screening happens at the right time. The colon cancer screening guidelines and recommendations that exist today are built on decades of research because following them works.
When people screen consistently, cancers are caught earlier and lives are saved. Book your primary care appointment with Aspen Valley Health today and let us help you take the right next step for your colon health.
